Skip to main content

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

NGNE holding history

Neurogene Inc. in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NGNE overviewAll 13F holders of NGNEFull Q2 2026 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q4 2022
Holdings of NGNE by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−9,682−100.0%Sold outConverted for a 1-for-5 splitHolders
Q2 202348,409$40.0K<0.1%00.0%UnchangedHolders
Q1 202348,409$34.0K<0.1%00.0%UnchangedHolders
Q4 202248,409$25.0K<0.1%+48,409NewHolders